non invasive prenatal testing

non invasive prenatal testing

With Market Size Valued at $2,557 Million by 2030, it`s an Encouraging Outlook for the United States Non Invasive Prenatal Testing Market

According to DPI Research Amid the COVID-19 crisis, the United States market for non invasive prenatal testing market estimated at US$ 788 million in the year 2021, is expected to reach a revised market size of US$ 2,557 Million by 2030, growing at a CAGR of 13.9% over the period 2021 – 2030. Download Free Report Sample: https://dpiresearch.com/request-a-free-sample-report/ The …

With Market Size Valued at $2,557 Million by 2030, it`s an Encouraging Outlook for the United States Non Invasive Prenatal Testing Market Read More »

prenatal testing

Non-Invasive Prenatal Testing | Market Size | CAGR | Forecast 2020 – 2025

DPI Research published a new report on Global Non-Invasive Prenatal Testing Market. The research offers an extensive analysis of key players active in the Global Non-Invasive Prenatal Testing Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research. Leading market players analyzed in the report include: Illumina, Natera, Sequenom Laboratories (LabCorp), Ariosa Diagnostics (Roche), BGI Diagnosis Co. Ltd, Berry Genomics, Quest Diagnostics, LifeCodexx AG, Premaitha Health, NIPD Genetics

prenatal testing

Non Invasive Prenatal Testing | Industry Market Report

DPI Research published a new report on Europe Non Invasive Prenatal Testing Market. The research offers an extensive analysis of key players active in the Europe Non Invasive Prenatal Testing Market. Detailed analysis on operating business segments, product portfolio, business performance, and key strategic developments is offered in the research. Leading market players analyzed in the report include: Ariosa Diagnostics (Roche), LifeCodexx AG, Premaitha Health PLC and NIPD Genetics.